Tecentriq Injection
By Tecentriq
Rx
14ml Injection in a Vial

Composition
Atezolizumab(840mg)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
October, 2025

liver
Limited information is available regarding the use of Tecentriq Injection in individuals with liver disease. It is recommended to consult with a healthcare professional regarding the safety and appropriateness of using Tecentriq Injection if you have liver issues.

kidney
Limited information is available regarding the use of Tecentriq Injection in patients with kidney disease. It is recommended to consult with your doctor for guidance.

alcohol
It is uncertain if consuming alcohol with Tecentriq Injection is safe. Please consult your doctor.

driving
When using Tecentriq Injection, it is unclear if it affects driving ability. Refrain from driving if you have symptoms affecting concentration and reaction.

pregnancy
Tecentriq Injection may not be safe to use during pregnancy as limited human studies show potential harm to the developing baby. Animal studies also indicate risks. Your doctor will assess benefits and risks before prescribing. Please consult your doctor before using Tecentriq Injection.

breastfeeding
Tecentriq Injection may not be safe to use while breastfeeding. There is limited data indicating the drug could enter breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | Peptides |
Therapeutic Class | - |
Action Class | Programmed Cell Death 1 (PD-1) Checkpoint Inhibitors |
₹277708
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025